Education
About Us
Working with TipRanks
Follow Us
Jonathan David Schwartz Insider Profile
4 Followers
Jonathan David Schwartz, Chief Medical & Gene Therapy Officer at Rocket Pharmaceuticals, holds 235.25K shares in Rocket Pharmaceuticals (Ticker: RCKT), holds 78.39K shares in Tabula Rasa HealthCare (Ticker: TRHC). Most recently, Jonathan David Schwartz Sold ― shares of Rocket Pharmaceuticals on May 22, 2025 for an estimated value of 5.16K.
Jonathan David Schwartz Rocket Pharmaceuticals (RCKT)Chief Medical & Gene Therapy Officer
Rocket Pharmaceuticals (RCKT)
Chief Medical & Gene Therapy Officer
Ranked #16,807 out of 102,674 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+30.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jonathan David Schwartz's holdings
Insider Roles
Chief Medical & Gene Therapy Officer
Roles that Jonathan David Schwartz holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jonathan David Schwartz
Jonathan David Schwartz's Trading History
Rocket Pharmaceuticals
May 22, 2025
Chief Medical & Gene Therapy Officer
Informative Sell
5.16K
$738.70K
Tabula Rasa HealthCare
Jun 13, 2023
―
Uninformative Buy
―
$823.07K
List of latest transactions for each holding click on a transaction to see Jonathan David Schwartz's performance on stock
You May Also Like
Jonathan David Schwartz insider profile FAQ
What is the percentage of profitable transactions made by Jonathan David Schwartz?
The percentage of profitable transactions made by Jonathan David Schwartz is 75%.
What is the average return per transaction made by Jonathan David Schwartz?
The average return per transaction made by Jonathan David Schwartz is 30.40%.
What stocks does Jonathan David Schwartz hold?
Jonathan David Schwartz holds: RCKT, TRHC stocks.
What was Jonathan David Schwartz’s latest transaction?
Jonathan David Schwartz latest transaction was an Informative Sell of $5.16K.
What was Jonathan David Schwartz's most profitable transaction?
Jonathan David Schwartz’s most profitable transaction was an Informative Sell of RCKT stock on February 27, 2025. The return on the trade was 66.50%.
What is Jonathan David Schwartz's role in Rocket Pharmaceuticals?
Jonathan David Schwartz's role in Rocket Pharmaceuticals is Chief Medical & Gene Therapy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.